Literature DB >> 19455193

Autosomal dominant polycystic kidney disease: the last 3 years.

Vicente E Torres1, Peter C Harris.   

Abstract

Autosomal dominant polycystic kidney disease is the most prevalent, potentially lethal monogenic disorder. It has large inter- and intra-familial variability explained to a large extent by its genetic heterogeneity and modifier genes. An increased understanding of its underlying genetic, molecular, and cellular mechanisms and a better appreciation of its progression and systemic manifestations have laid out the foundation for the development of clinical trials and potentially effective therapies. The purpose of this review is to update the core of knowledge in this area with recent publications that have appeared during 2006-2009.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19455193      PMCID: PMC2812475          DOI: 10.1038/ki.2009.128

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  175 in total

1.  Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases.

Authors:  Luca Fabris; Massimiliano Cadamuro; Romina Fiorotto; Tania Roskams; Carlo Spirlì; Saida Melero; Aurelio Sonzogni; Ruth E Joplin; Lajos Okolicsanyi; Mario Strazzabosco
Journal:  Hepatology       Date:  2006-05       Impact factor: 17.425

Review 2.  Autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris; Yves Pirson
Journal:  Lancet       Date:  2007-04-14       Impact factor: 79.321

3.  Increased water intake decreases progression of polycystic kidney disease in the PCK rat.

Authors:  Shizuko Nagao; Kazuhiro Nishii; Makoto Katsuyama; Hiroki Kurahashi; Tohru Marunouchi; Hisahide Takahashi; Darren P Wallace
Journal:  J Am Soc Nephrol       Date:  2006-06-28       Impact factor: 10.121

4.  Pyloric stenosis in a newborn baby with polycystic kidneys.

Authors:  J Tennakoon; T H H G Koh; G Alcock
Journal:  J Perinatol       Date:  2007-02       Impact factor: 2.521

5.  Characterization of human renal stones with MDCT: advantage of dual energy and limitations due to respiratory motion.

Authors:  Romain Grosjean; Benoît Sauer; Rui Matias Guerra; Michel Daudon; Alain Blum; Jacques Felblinger; Jacques Hubert
Journal:  AJR Am J Roentgenol       Date:  2008-03       Impact factor: 3.959

6.  A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease.

Authors:  Raoul Zeltner; Karl F Hilgers; Roland E Schmieder; Markus Porst; Bernd D Schulze; Andrea Hartner
Journal:  Nephron Clin Pract       Date:  2008-02-14

7.  Centrosome overduplication and mitotic instability in PKD2 transgenic lines.

Authors:  Stéphane Burtey; Marta Riera; Emilie Ribe; Petra Pennenkamp; Roselyne Rance; Judith Luciani; Bernd Dworniczak; Marie Geneviève Mattei; Michel Fontés
Journal:  Cell Biol Int       Date:  2008-08-06       Impact factor: 3.612

8.  TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex.

Authors:  Yu Tian; Robert Kolb; Jeong-Ho Hong; John Carroll; Dawei Li; John You; Roderick Bronson; Michael B Yaffe; Jing Zhou; Thomas Benjamin
Journal:  Mol Cell Biol       Date:  2007-07-16       Impact factor: 4.272

9.  A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease.

Authors:  Xiaogang Li; Brenda S Magenheimer; Sheng Xia; Teri Johnson; Darren P Wallace; James P Calvet; Rong Li
Journal:  Nat Med       Date:  2008-06-15       Impact factor: 53.440

10.  p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels.

Authors:  Jin-Young Park; William E Schutzer; Jessie N Lindsley; Susan P Bagby; Terry T Oyama; Sharon Anderson; Robert H Weiss
Journal:  BMC Nephrol       Date:  2007-08-22       Impact factor: 2.388

View more
  224 in total

1.  MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein.

Authors:  M Rafiq Islam; Tamara Jimenez; Christopher Pelham; Marianna Rodova; Sanjeev Puri; Brenda S Magenheimer; Robin L Maser; Christian Widmann; James P Calvet
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Scattered Deletion of PKD1 in Kidneys Causes a Cystic Snowball Effect and Recapitulates Polycystic Kidney Disease.

Authors:  Wouter N Leonhard; Malu Zandbergen; Kimberley Veraar; Susan van den Berg; Louise van der Weerd; Martijn Breuning; Emile de Heer; Dorien J M Peters
Journal:  J Am Soc Nephrol       Date:  2014-10-31       Impact factor: 10.121

3.  Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective.

Authors:  Shobha Ratnam; Surya M Nauli
Journal:  Int J Nephrol Urol       Date:  2010

4.  Blood pressure in early autosomal dominant polycystic kidney disease.

Authors:  Robert W Schrier; Kaleab Z Abebe; Ronald D Perrone; Vicente E Torres; William E Braun; Theodore I Steinman; Franz T Winklhofer; Godela Brosnahan; Peter G Czarnecki; Marie C Hogan; Dana C Miskulin; Frederic F Rahbari-Oskoui; Jared J Grantham; Peter C Harris; Michael F Flessner; Kyongtae T Bae; Charity G Moore; Arlene B Chapman
Journal:  N Engl J Med       Date:  2014-11-15       Impact factor: 91.245

5.  Inhibition of the P2X7 receptor reduces cystogenesis in PKD.

Authors:  Ming-Yang Chang; Jenn-Kan Lu; Ya-Chung Tian; Yung-Chang Chen; Cheng-Chieh Hung; Yi-Hui Huang; Yau-Hung Chen; Mai-Szu Wu; Chih-Wei Yang; Yi-Chuan Cheng
Journal:  J Am Soc Nephrol       Date:  2011-06-02       Impact factor: 10.121

Review 6.  Polycystic liver diseases: congenital disorders of cholangiocyte signaling.

Authors:  Mario Strazzabosco; Stefan Somlo
Journal:  Gastroenterology       Date:  2011-04-22       Impact factor: 22.682

7.  Primary cilia regulate mTORC1 activity and cell size through Lkb1.

Authors:  Christopher Boehlke; Fruzsina Kotsis; Vishal Patel; Simone Braeg; Henriette Voelker; Saskia Bredt; Theresa Beyer; Heike Janusch; Christoph Hamann; Markus Gödel; Klaus Müller; Martin Herbst; Miriam Hornung; Mara Doerken; Michael Köttgen; Roland Nitschke; Peter Igarashi; Gerd Walz; E Wolfgang Kuehn
Journal:  Nat Cell Biol       Date:  2010-10-24       Impact factor: 28.824

8.  A novel long-range PCR sequencing method for genetic analysis of the entire PKD1 gene.

Authors:  Ying-Cai Tan; Alber Michaeel; Jon Blumenfeld; Stephanie Donahue; Tom Parker; Daniel Levine; Hanna Rennert
Journal:  J Mol Diagn       Date:  2012-05-16       Impact factor: 5.568

9.  A novel model of autosomal recessive polycystic kidney questions the role of the fibrocystin C-terminus in disease mechanism.

Authors:  Patricia Outeda; Luis Menezes; Erum A Hartung; Stacey Bridges; Fang Zhou; Xianjun Zhu; Hangxue Xu; Qiong Huang; Qin Yao; Feng Qian; Gregory G Germino; Terry Watnick
Journal:  Kidney Int       Date:  2017-07-18       Impact factor: 10.612

10.  Centrosomal abnormalities characterize human and rodent cystic cholangiocytes and are associated with Cdc25A overexpression.

Authors:  Tatyana V Masyuk; Seung-Ok Lee; Brynn N Radtke; Angela J Stroope; Bing Huang; Jesús M Banales; Anatoliy I Masyuk; Patrick L Splinter; Sergio A Gradilone; Gabriella B Gajdos; Nicholas F LaRusso
Journal:  Am J Pathol       Date:  2013-11-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.